bioMerieux Polska Sp. z o.o. secures contract for Diagnostic agents 175 WR ZP D 2025 Supplies of reagents for Multiplex PCR tests in blood cerebrospinal fluid synovial fluid and respiratory tract on the Biofire device

Poland, March 13 -- Poland based bioMerieux Polska Sp. z o.o. has secured contract from Samodzielny Publiczny Zaklad Opieki Zdrowotnej Uniwersytecki Szpital Kliniczny nr 2 Uniwersytetu Medycznego w Lodzi for Diagnostic agents 175 WR ZP D 2025 Supplies of reagents for Multiplex PCR tests in blood cerebrospinal fluid synovial fluid and respiratory tract on the Biofire device. The value of the contract is worth 64250784000 PLN.

Published by HT Digital Content Services with permission from Pivotal Sources....